FDA grants premarket approval for patient-specific skull implants from Walter Reed's 3D Medical Applications Center

The 3D Medical Applications Center (3D MAC) at Walter Reed National Military Medical Center has received FDA premarket approval to produce patient-specific titanium skull plates for active U.S. service members with traumatic head injuries. The implants are manufactured on-site at the medical center, with support from 3D Systems, which helped optimize implant design, establish process controls, and prepare regulatory documentation over several years. The approval covers the full workflow, from 3D image data segmentation to digital modeling, LPBF printing, and quality-assured post-processing, including material traceability, dimensional accuracy, and sterilization.

This decision marks a significant step beyond anatomical models and surgical guides, demonstrating that in-house clinical 3D printing centers can achieve regulatory clearance for implantable devices. The Defense Health Agency and Department of Veterans Affairs involvement suggests this could serve as a template for other patient-specific medical devices across U.S. defense and veteran healthcare facilities. For 3D Systems, the collaboration reinforces its position in point-of-care manufacturing, which CEO Jeff Graves highlighted as a long-term growth driver.

The practical implication is that hospital-based AM centers can now navigate the regulatory pathway for implants, but only with validated equipment, trained personnel, and rigorously controlled processes. This approval may accelerate adoption of point-of-care manufacturing for other custom implants, though the qualification burden remains substantial.